Canada markets closed

Love Pharma Inc. (LUV.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
0.0125+0.0025 (+25.00%)
At close: 10:52AM EDT

Love Pharma Inc.

355 Burrard Street
Suite 1780
Vancouver, BC V7X 1B1
Canada
604 343 2977
https://love-pharma.com

Sector(s)Healthcare
IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. Zachary T. StadnykPres, CEO & Chairman91.7kN/A1993
Ms. Tatiana KovalevaChief Financial Officer2kN/A1959
Mr. Joshua MauriceCOO & Vice-Pres of SalesN/AN/A1979
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

Love Pharma Inc. focuses on mental health and sexual wellness by licensing and distributing psychedelic and hemp–infused products in North America, the United Kingdom, and Europe. It offers BLOOM, a female arousal gel; and AURALIEF, a cannabis-infused sublingual strip. The company was founded in 2020 and is headquartered in Vancouver, Canada.

Corporate Governance

Love Pharma Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.